BIOCYTOGEN PHARMA. H YC1 (I54) — Tangible Net Worth Ratio
BIOCYTOGEN PHARMA. H YC1 (I54) has a Tangible Net Worth Ratio of 99.4% as of December 2025. This metric is calculated by deducting intangible assets (€13.36 Million) from net assets (€2.18 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore BIOCYTOGEN PHARMA. H YC1 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
BIOCYTOGEN PHARMA. H YC1 Tangible Net Worth Ratio (2021–2025)
This chart shows how BIOCYTOGEN PHARMA. H YC1's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 99.4%, reflecting net assets of €2.18 Billion with intangible assets of €13.36 Million EUR. For live market cap and overall valuation, see BIOCYTOGEN PHARMA. H YC1 market cap and net worth.
Annual Tangible Net Worth Ratio for BIOCYTOGEN PHARMA. H YC1 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for BIOCYTOGEN PHARMA. H YC1 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore BIOCYTOGEN PHARMA. H YC1 (I54) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.4% | €2.18 Billion | €13.36 Million | €3.72 Billion | ▲ +1.9 pp |
| 2024 | 97.5% | €838.60 Million | €20.66 Million | €2.42 Billion | ▲ +1.1 pp |
| 2023 | 96.4% | €790.44 Million | €28.13 Million | €2.45 Billion | ▼ -0.9 pp |
| 2022 | 97.3% | €1.15 Billion | €30.65 Million | €2.80 Billion | ▼ -2.2 pp |
| 2021 | 99.5% | €1.25 Billion | €6.05 Million | €2.30 Billion | — |